[ad_1]
The US Food and Drug Administration claims to be one of the first-to-date cancer tests.
The new recall of losartan potassium hydrochlorothiazide is sold by the company Sandoz. The voluntary recall only involves 100 milligram / 25 milligram tablets, it does not involve the other versions of the drug, sometimes sold under the brand names Hyzaar. If you take Sandoz's losartan potassium, look on the bottle for the lot number. If it has the lot number JB8912, then you have the recalled pills. Patients use these drugs to keep their blood pressure in check.
The drug is tested for N-Nitrosodiethylamine or NDEA, a suspected human and animal carcinogen that is used as a stabilizer for a lubricant additive, according to the National Institutes of Health.
The ingredient was made by Zhejiang Huahai Pharmaceutical Company Co. Ltd. The FDA places the Chinese company on an import alert to the end of September, meaning that it will not be permitted to enter the United States. The FDA made that decision after an inspection of the facility.
Several pills that contain valsartan, another drug used by heart patients, have been under a recall since July. The drugs have been treated with NDEA or NDMA, N-nitrosodimethylamine, an impurity that is also considered a possible carcinogen by the US Environmental Protection Agency.
NDMA is an organic chemical used to make liquid rocket fuel and is a byproduct of manufacturing some pesticides and processing fish. It can be unintentionally introduced into the industry through certain chemical reactions.
The ARBs for these impurities.
Not all medicine containing valsartan is recalled. The FDA keeps an eye on the list of products that are not listed.
The latest recalls impacts less than 1% of the total market in the US market, according to the FDA.
If your drug is on the list, the FDA Because you are not involved in the recall, you may be able to switch to another company.
It's unclear exactly what the cancer risk is if you take the poisonsartan pills; the FDA believed that the risk was low with the valsartan recall.
It was estimated that 8,000 people took the highest dose of valsartan (320 milligrams) containing these daily batches, which are estimated to be over 8000 people. Many patients take a much lower dose of valsartan, and therefore their risks are theoretically much lower.
The FDA says that it will continue to be used in the presence of impurities.
Source link
